In the fall of 1994, Strasbourg witnessed a remarkable migration. In addition to the habitual departure of the storks of Alsace heading for warmer climes, some 400 scientists and support staff left the Institut Chimie Biologique of the Faculty of Medicine of the University Louis Pasteur to resume their research in the custom-built Institut de Genetique et Biologie Moleculaire et Cellulaire, 5 km to the south in the Illkirch Innovation Park (Fig. 1) .
This move was the logical, but far from inevitable, consequence of the continual growth of an idea. In the late 1 960s, when Pierre Chambon returned to France from Arthur Kornberg's laboratory in Stanford and set up his new group with the goal of understanding the control of gene expression in eukaryotes, it was a small but happy band of five. The group, however, soon began to expand, keeping pace with the growth of the discipline.
The first major research topic to be pursued was the characterization of eukaryotic DNA-dependant RNA polymerases, which to a group of biochemists represented the key enzymes for understanding transcription. Thereafter, the scientists focussed their efforts on the chromatin template and on resolving the nucleosome structure of DNA, which was proving to be an obstacle to the activity of these polymerases. In search of a more amenable experimental system, they were among the first groups to exploit the possibilities offered by the molecular revolution that marked the mid 1970s. Starting with the now simplistic idea of using recombinant DNA technology to isolate a well known "steroid controlled" gene, they fell upon the phenomenon of "split genes" and subsequently characterized exon-intron structures of eukaryotic genes. As these struc- In contrast to most French research laboratories, the number of tenured scientists is kept low (about a quarter of the total), ensuring the continual renewal of ideas. During their stay at the IGBMC, young scientists receive a broad training in the molecular techniques which are increasingly applicable to human health problems. The Institute itself was designed with an eye to the future rather than the present. In particular, laboratories were planned to be as flexible as possible, to accommodate changes in both techniques and in the research groups of the Institute. Personalized areas were kept to the strict minimum.
The IGBMC is a laboratory without doors. The twin central towers house four floors of research laboratories split into north and south wings separated by a glass walled atrium with its "coffee corners". The larger ground floor includes the library, a 200-seat lecture theater and the cafeteria, as well as the central administration, core facilities, and workshops. As designed by the California-based architect Ken Kornberg, the 63 standard laboratory modules are linked to the common technical spaces by a series of internal corridors that encourage a continual flow of people and ideas. This is essential, since despite the apparent differences in today's themes and model systems, the organization of genetic programs and the techniques for their study are shared features, and advances in both knowledge and techniques pass rapidly from group to group. This philosophy of sharing is reinforced in practice by the emphasis on core service support in the Institute. The future of fundamental biological research, and by association of molecular medicine, lies in centers that can provide as complete a range of investigative techniques as possible. In the Institute, core services ensure DNA and peptide sequencing and synthesis, cell culture, monoclonal and polyclonal antibody production, the production and maintenance of transgenic animals, molecular hybridization and histology for light and electron microscopy, 3-D tissue reconstruction, bio-computing, etc. By drawing on these resources, a group at the IGBMC can be as competitive as one twice its size in a conventional institute.
With these exceptional research tools, the present and future research groups of the IGBMC are and will be equipped for the 21st century, which is foreseen as the golden age of molecular medicine.
